Market Place
Sourcing Support
Skyhawk Receives Australian Approval to SKY-0515 in Huntington
09 Dec 2024 //
PR NEWSWIRE
Skyhawk Presents SKY-1214 Data At EORTC-NCI-AACR Symposium
24 Oct 2024 //
PR NEWSWIRE
Skyhawk To Present SKY-0515 Phase 1 Data At Huntington`s Disease Network
11 Sep 2024 //
PR NEWSWIRE
Skyhawk Reports Positive Phase 1 Results For SKY-0515 In Huntington`s
10 Jul 2024 //
GLOBENEWSWIRE
Haney Becomes Skyhawk Chairman Bayer Parts With Biotech Head
14 Jun 2024 //
ENDPTS
Skyhawk Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder
11 Jun 2024 //
GLOBENEWSWIRE
Ipsen signs $1.8bn RNA drug alliance with Skyhawk
23 Apr 2024 //
PRESS RELEASE
Skyhawk Has Advanced to the MAD Portion of its Phase 1 Study evaluating SKY-0515
28 Feb 2024 //
PR NEWSWIRE
Big Pharma can`t get enough from drugging RNA
29 Sep 2021 //
ENDPTS
Bill Haney adds another $133M to Skyhawk`s coffers
14 Sep 2021 //
ENDPTS
Aragen, Skyhawk partner to develop molecules that correct RNA expression
15 Jul 2021 //
EXPRESS PHARMA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.